CLARIVATE PLC
CLVTNYSETrading Snapshot
- Day Range
- $1.69 β $1.73
- 52-Week Range
- $1.66 β $3.96
- Volume
- $2.55B
- Avg Volume
- $2.99B
- Shares Outstanding
- 639.7M
- Next Earnings
- Nov 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $2.46B
- Last Q Revenue
- $587M
- P/E Ratio
- -3.3
- P/S Ratio
- 0.5x
- EPS (TTM)
- $-0.52
- Dividend Yield
- 0.00%
- Dilution (1yr)
- β5.8%
Why Investors Own CLVT
- βHigh-growth profile β revenue up +24.2% YoY with expanding US Equity exposure.
- βHealthy economics β 25% gross margin and 18% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CLARIVATE PLC
CLVTAbout CLARIVATE PLC
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

Clarivate Announces Final Results of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
LONDON, Sept. 24, 2026 /PRNewswire/ -- Clarivate PlcΒ (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the expiration and final results of its previously announced cash

Clarivate Announces Pricing Terms of Offer to Purchase for Cash Certain of its Outstanding Debt Securities
LONDON, Sept. 23, 2026 /PRNewswire/ -- Clarivate PlcΒ (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced the Reference Yield and Total Consideration (as set forth in the

Clarivate to Report Third Quarter 2026 Results on November 3, 2026
LONDON, Sept. 22, 2026 /PRNewswire/ -- (PR Newswire) - Clarivate PlcΒ (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the third quarter 2026

Clarivate PLC (NYSE:CLVT) Receives $3.02 Consensus Price Target from Brokerages
Shares of Clarivate PLC (NYSE: CLVT - Get Free Report) have earned a consensus recommendation of "Reduce" from the seven brokerages that are currently covering the company, MarketBeat.com reports. Three investment analys

Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities
NEW YORK, Sept. 17, 2026 /PRNewswire/ -- Clarivate PlcΒ (NYSE: CLVT) ("Clarivate"), a leading global provider of transformative intelligence, today announced that its wholly-owned subsidiary, Clarivate Science Holdings Co

Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific BreakthroughsPR NewswireLONDON, Sept. 17, 202622 researchers honored for Nobel-c